$CELC 8-K SEC Filings

Filed On	Filing
02 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure Mr. Gryska brings decades of strategic and financial leadership experience to Celcuity’s Board
30 Sep 2026	8-K: Regulation FD Disclosure; Other Events REVTORPYK is indicated for patients with HR+/HER2- advanced breast cancer without a PIK3CA mutation detected following progression on or after at least one line of endocrine therapy in the metastatic setting
26 Aug 2026	8-K: Regulation FD Disclosure; Other Events
13 Aug 2026	8-K: Results of Operations and Financial Condition
15 Jul 2026	8-K: Regulation FD Disclosure; Other Events
08 Jun 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +2 more
02 Jun 2026	8-K: Regulation FD Disclosure; Other Events
18 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
14 May 2026	8-K: Results of Operations and Financial Condition
01 May 2026	8-K: Regulation FD Disclosure; Other Events
25 Mar 2026	8-K: Results of Operations and Financial Condition
12 Feb 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
17 Nov 2025	8-K: Regulation FD Disclosure; Other Events
12 Nov 2025	8-K: Results of Operations and Financial Condition
20 Oct 2025	8-K: Regulation FD Disclosure; Other Events
10 Sep 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
14 Aug 2025	8-K: Results of Operations and Financial Condition
01 Aug 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
31 Jul 2025	8-K: Entry into a Material Definitive Agreement; Other Events
29 Jul 2025	8-K: Entry into a Material Definitive Agreement; Other Events

Comments